During the past decade, Henry-Joyce Cancer Clinic conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 17 clinical trials were completed, i.e. on average, 73.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henry-Joyce Cancer Clinic" #1 sponsor was "Pfizer" with 15 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Kite, A Gilead Company" with 2 trials sponsored and "SpringWorks Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry-Joyce Cancer Clinic" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Henry-Joyce Cancer Clinic" are "Breast Cancer" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Advanced Solid Tumors" (3 trials), "Chronic Myelomonocytic Leukemia" (2 trials) and "Renal Cell Cancer" (2 trials). Many other conditions were trialed in "Henry-Joyce Cancer Clinic" in a lesser frequency.

Most popular intervention types in "Henry-Joyce Cancer Clinic" are "Drug" (34 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (3 trials), "Cetuximab" (3 trials), "Avelumab (MSB0010718C)" (2 trials), "Axitinib (AG-013736)" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Henry-Joyce Cancer Clinic" are 32 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Henry-Joyce Cancer Clinic". undefined are not yet recruiting, 3 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Henry-Joyce Cancer Clinic, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Henry-Joyce Cancer Clinic, 13 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".